Chronic inflammatory immune-mediated diseases and immunosuppressive drugs: What evidence would you like to see generated from real-world data?

Study identification

• EU PAS number:
  EUPAS1000000982
• Study ID:
  1000000982
• Official title and acronym:
  Chronic inflammatory immune-mediated diseases and immunosuppressive drugs: What evidence would you like to see generated from real-world data?
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  This work aims to identify and characterise current clinical areas that should be prioritized using RWD from both patient and clinician perspectives in IMIDs, using a dedicated survey administered to both groups. As a secondary objective, differences in prioritization distributions between clinicians and patients will be analyzed.
• Study status:
  Finalised

Research institutions and networks

Institutions

University of Verona

Study timelines

Date when funding contract was signed

Planned:16/04/2026

Actual:16/04/2026

Study start date

Planned:01/01/2025

Actual:01/01/2025

Date of final study report

Planned:15/12/2026

Actual:16/04/2026

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable